BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38744290)

  • 1. A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.
    Nguyen HTL; Kohl E; Bade J; Eng SE; Tosevska A; Al Shihabi A; Tebon PJ; Hong JJ; Dry S; Boutros PC; Panossian A; Gosline SJC; Soragni A
    Cell Rep Methods; 2024 May; 4(5):100772. PubMed ID: 38744290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas.
    Ly I; Romo CG; Gottesman S; Kelly KM; Kornacki D; York Z; Lee SY; Rhodes SD; Staedtke V; Steensma MR; Blakeley JO; Wolkenstein P
    J Invest Dermatol; 2023 Aug; 143(8):1388-1396. PubMed ID: 37294242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.
    Rhodes SD; McCormick F; Cagan RL; Bakker A; Staedtke V; Ly I; Steensma MR; Lee SY; Romo CG; Blakeley JO; Sarin KY
    J Invest Dermatol; 2023 Aug; 143(8):1358-1368. PubMed ID: 37245145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous neurofibromas: Current clinical and pathologic issues.
    Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
    Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex Vivo Patient-Derived Explant Model for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.
    Grit JL; Turner L; Essenburg CJ; Gallik KL; Dischinger PS; Shurlow ND; Pate MJ; Graveel CR; Steensma MR
    J Invest Dermatol; 2024 Feb; ():. PubMed ID: 38395106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.
    Staedtke V; Topilko P; Le LQ; Grimes K; Largaespada DA; Cagan RL; Steensma MR; Stemmer-Rachamimov A; Blakeley JO; Rhodes SD; Ly I; Romo CG; Lee SY; Serra E
    J Invest Dermatol; 2023 Aug; 143(8):1378-1387. PubMed ID: 37330719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods.
    Richey P; Funk M; Sakamoto F; Plotkin S; Ly I; Jordan J; Muzikansky A; Roberts J; Farinelli W; Levin Y; Garibyan L; Blakeley JO; Anderson RR
    J Am Acad Dermatol; 2024 Apr; 90(4):767-774. PubMed ID: 38086517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.
    Kallionpää RA; Peltonen S; Le KM; Martikkala E; Jääskeläinen M; Fazeli E; Riihilä P; Haapaniemi P; Rokka A; Salmi M; Leivo I; Peltonen J
    Lab Invest; 2024 Jan; 104(1):100285. PubMed ID: 37949359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
    Jiang C; McKay RM; Lee SY; Romo CG; Blakeley JO; Haniffa M; Serra E; Steensma MR; Largaespada D; Le LQ
    J Invest Dermatol; 2023 Aug; 143(8):1369-1377. PubMed ID: 37318402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey.
    Guiraud M; Bouroubi A; Beauchamp R; Bocquet A; Grégoire JM; Rauly-Lestienne I; Blanco I; Wolkenstein P; Schmitt AM
    Orphanet J Rare Dis; 2019 Dec; 14(1):286. PubMed ID: 31801570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience.
    Peltonen S; Jannic A; Wolkenstein P
    Eur J Med Genet; 2022 Jan; 65(1):104386. PubMed ID: 34768015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1.
    Chamseddin BH; Hernandez L; Solorzano D; Vega J; Le LQ
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31038470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Clinicopathologic Study on the Role of Estrogen, Progesterone, and Their Classical and Nonclassical Receptors in Cutaneous Neurofibromas of Individuals With Neurofibromatosis 1.
    Rozza-de-Menezes RE; Almeida LM; Andrade-Losso RM; de Souza Vieira G; Siqueira OHK; Brum CI; Riccardi VM; Cunha KS
    Am J Clin Pathol; 2021 Apr; 155(5):738-747. PubMed ID: 33289020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.
    Cannon A; Sarin KY; Petersen AK; Pichard DC; Wolters PL; Erickson G; Lessing AJ; Li P; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR
    Clin Trials; 2024 Feb; 21(1):67-72. PubMed ID: 37269078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report.
    Sassi I; Bouida MA; Hasnaoui A; Zemni I; Ben Dhieb T
    J Med Case Rep; 2024 Jan; 18(1):15. PubMed ID: 38216958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1.
    Kallionpää RA; Ahramo K; Martikkala E; Fazeli E; Haapaniemi P; Rokka A; Leivo I; Harvima IT; Peltonen J; Peltonen S
    Dermatology; 2022; 238(2):329-339. PubMed ID: 34237737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.
    Cannon A; Chen MJ; Li P; Boyd KP; Theos A; Redden DT; Korf B
    Orphanet J Rare Dis; 2018 Feb; 13(1):31. PubMed ID: 29415745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Econazole selectively induces cell death in NF1-homozygous mutant tumor cells.
    Lakes YB; Moye SL; Mo J; Tegtmeyer M; Nehme R; Charlton M; Salinas G; McKay RM; Eggan K; Le LQ
    Cell Rep Med; 2023 Dec; 4(12):101309. PubMed ID: 38086379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.
    Mazuelas H; Magallón-Lorenz M; Uriarte-Arrazola I; Negro A; Rosas I; Blanco I; Castellanos E; Lázaro C; Gel B; Carrió M; Serra E
    JCI Insight; 2024 Jan; 9(3):. PubMed ID: 38175707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomus-like bodies within a neurofibroma: a novel neoplasm arising in neurofibromatosis type 1 or a coincidence?
    Thareja S; Honigbaum A; Jukic D
    J Cutan Pathol; 2015 Apr; 42(4):285-8. PubMed ID: 25384450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.